Last reviewed · How we verify

NCT03414515

Endovascular Treatment of Peripheral Artery Disease (PAD)

Completed Last updated 5 September 2024
What this trial tests

trial testing Endovascular intervention in Peripheral Arterial Disease in 200 participants. Completed in 1 December 2021.

Timeline
2 May 2018
Primary endpoint
1 December 2021
1 December 2021

Quick facts

Lead sponsorDuomed
StatusCompleted
Study typeOBSERVATIONAL
Enrollment200
Start date2 May 2018
Primary completion1 December 2021
Estimated completion1 December 2021
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Duomed

Who can join

18 and older, any sex, with Peripheral Arterial Disease or Iliac Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this observational study is to evaluate the performance and safety of endovascular treatment with stenting (Optimed Sinus Superflex 635 or Qualimed Pontos-pp) or balloon angioplasty (Cardionovum Legflow or Optimed Nylotrack .035 + .018) according to current practice. The goal of the study will be achieved by assessing binary restenosis with duplex ultrasound, peri- and postoperative complications, technical success, target lesion revascularization, amputation and clinical outcome.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Angioplasty versus stenting for iliac artery lesions.
    Jongsma H, Bekken J, Ayez N, Hoogewerf CJ, et al · · 2020 · cited 12× · PMID 33258499 · DOI 10.1002/14651858.cd007561.pub3

Verify or expand the search:

Other trials of Endovascular intervention

Trials testing the same drug.

Other recruiting trials for Peripheral Arterial Disease

Currently open trials in the same condition.

Other Duomed trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03414515.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing